BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22355095)

  • 1. Rescue of Mtp siRNA-induced hepatic steatosis by DGAT2 siRNA silencing.
    Tep S; Mihaila R; Freeman A; Pickering V; Huynh F; Tadin-Strapps M; Stracks A; Hubbard B; Caldwell J; Flanagan WM; Kuklin NA; Ason B
    J Lipid Res; 2012 May; 53(5):859-867. PubMed ID: 22355095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perilipin 5 promotes hepatic steatosis in dairy cows through increasing lipid synthesis and decreasing very low density lipoprotein assembly.
    Jia H; Li X; Liu G; Loor JJ; Bucktrout R; Sun X; Li G; Shu X; Dong J; Wang Y; Zuo R; Wang Z; Li X
    J Dairy Sci; 2019 Jan; 102(1):833-845. PubMed ID: 30415861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very Low Density Lipoprotein Assembly Is Required for cAMP-responsive Element-binding Protein H Processing and Hepatic Apolipoprotein A-IV Expression.
    Cheng D; Xu X; Simon T; Boudyguina E; Deng Z; VerHague M; Lee AH; Shelness GS; Weinberg RB; Parks JS
    J Biol Chem; 2016 Nov; 291(45):23793-23803. PubMed ID: 27655915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordinate transcriptional repression of liver fatty acid-binding protein and microsomal triglyceride transfer protein blocks hepatic very low density lipoprotein secretion without hepatosteatosis.
    Spann NJ; Kang S; Li AC; Chen AZ; Newberry EP; Davidson NO; Hui ST; Davis RA
    J Biol Chem; 2006 Nov; 281(44):33066-77. PubMed ID: 16950764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of acyl-CoA:diacylglycerol acyltransferase 2 with antisense oligonucleotide reduces VLDL TG and ApoB secretion in mice.
    Liu Y; Millar JS; Cromley DA; Graham M; Crooke R; Billheimer JT; Rader DJ
    Biochim Biophys Acta; 2008 Mar; 1781(3):97-104. PubMed ID: 18252207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An RNAi therapeutic targeting hepatic DGAT2 in a genetically obese mouse model of nonalcoholic steatohepatitis.
    Yenilmez B; Wetoska N; Kelly M; Echeverria D; Min K; Lifshitz L; Alterman JF; Hassler MR; Hildebrand S; DiMarzio C; McHugh N; Vangjeli L; Sousa J; Pan M; Han X; Brehm MA; Khvorova A; Czech MP
    Mol Ther; 2022 Mar; 30(3):1329-1342. PubMed ID: 34774753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice.
    Yu XX; Murray SF; Pandey SK; Booten SL; Bao D; Song XZ; Kelly S; Chen S; McKay R; Monia BP; Bhanot S
    Hepatology; 2005 Aug; 42(2):362-71. PubMed ID: 16001399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
    Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
    Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance.
    Choi CS; Savage DB; Kulkarni A; Yu XX; Liu ZX; Morino K; Kim S; Distefano A; Samuel VT; Neschen S; Zhang D; Wang A; Zhang XM; Kahn M; Cline GW; Pandey SK; Geisler JG; Bhanot S; Monia BP; Shulman GI
    J Biol Chem; 2007 Aug; 282(31):22678-88. PubMed ID: 17526931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trivalent chromium alleviates oleic acid induced steatosis in SMMC-7721 cells by decreasing fatty acid uptake and triglyceride synthesis.
    Wang S; Wang J; Zhang X; Hu L; Fang Z; Huang Z; Shi P
    Biometals; 2016 Oct; 29(5):881-92. PubMed ID: 27497686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ApoB siRNA-induced liver steatosis is resistant to clearance by the loss of fatty acid transport protein 5 (Fatp5).
    Ason B; Castro-Perez J; Tep S; Stefanni A; Tadin-Strapps M; Roddy T; Hankemeier T; Hubbard B; Sachs AB; Michael Flanagan W; Kuklin NA; Mitnaul LJ
    Lipids; 2011 Nov; 46(11):991-1003. PubMed ID: 21826528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ω-3 fatty acids prevent hepatic steatosis, independent of PPAR-α activity, in a murine model of parenteral nutrition-associated liver disease.
    Prince E; Lazare FB; Treem WR; Xu J; Iqbal J; Pan X; Josekutty J; Walsh M; Anderson V; Hussain MM; Schwarz SM
    JPEN J Parenter Enteral Nutr; 2014 Jul; 38(5):608-16. PubMed ID: 23757305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordinated alteration of hepatic gene expression in fatty acid and triglyceride synthesis in LCAT-null mice is associated with altered PUFA metabolism.
    Song H; Zhu L; Picardo CM; Maguire G; Leung V; Connelly PW; Ng DS
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E17-E25. PubMed ID: 16105858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DGAT2 Inhibition Alters Aspects of Triglyceride Metabolism in Rodents but Not in Non-human Primates.
    McLaren DG; Han S; Murphy BA; Wilsie L; Stout SJ; Zhou H; Roddy TP; Gorski JN; Metzger DE; Shin MK; Reilly DF; Zhou HH; Tadin-Strapps M; Bartz SR; Cumiskey AM; Graham TH; Shen DM; Akinsanya KO; Previs SF; Imbriglio JE; Pinto S
    Cell Metab; 2018 Jun; 27(6):1236-1248.e6. PubMed ID: 29706567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in hepatic microsomal triglyceride transfer protein and triglyceride in periparturient dairy cattle.
    Bremmer DR; Bertics SJ; Besong SA; Grummer RR
    J Dairy Sci; 2000 Oct; 83(10):2252-60. PubMed ID: 11049065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and regulation of hamster microsomal triglyceride transfer protein. The regulation is independent from that of other hepatic and intestinal proteins which participate in the transport of fatty acids and triglycerides.
    Lin MC; Arbeeny C; Bergquist K; Kienzle B; Gordon DA; Wetterau JR
    J Biol Chem; 1994 Nov; 269(46):29138-45. PubMed ID: 7961879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased microsomal triglyceride transfer protein activity contributes to initiation of alcoholic liver steatosis in rats.
    Sugimoto T; Yamashita S; Ishigami M; Sakai N; Hirano K; Tahara M; Matsumoto K; Nakamura T; Matsuzawa Y
    J Hepatol; 2002 Feb; 36(2):157-62. PubMed ID: 11830326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term overexpression of DGAT1 or DGAT2 increases hepatic triglyceride but not VLDL triglyceride or apoB production.
    Millar JS; Stone SJ; Tietge UJ; Tow B; Billheimer JT; Wong JS; Hamilton RL; Farese RV; Rader DJ
    J Lipid Res; 2006 Oct; 47(10):2297-305. PubMed ID: 16877777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesis.
    Bai X; Hong W; Cai P; Chen Y; Xu C; Cao D; Yu W; Zhao Z; Huang M; Jin J
    Toxicol Appl Pharmacol; 2017 Jun; 324():12-25. PubMed ID: 28366540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model.
    Shindo N; Fujisawa T; Sugimoto K; Nojima K; Oze-Fukai A; Yoshikawa Y; Wang X; Yasuda O; Ikegami H; Rakugi H
    J Hepatol; 2010 Jun; 52(6):903-12. PubMed ID: 20392512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.